IL107432A0 - Soluble lymphocyte receptor protein and a method for modulating leukocyte function - Google Patents

Soluble lymphocyte receptor protein and a method for modulating leukocyte function

Info

Publication number
IL107432A0
IL107432A0 IL107432A IL10743293A IL107432A0 IL 107432 A0 IL107432 A0 IL 107432A0 IL 107432 A IL107432 A IL 107432A IL 10743293 A IL10743293 A IL 10743293A IL 107432 A0 IL107432 A0 IL 107432A0
Authority
IL
Israel
Prior art keywords
receptor protein
lymphocyte receptor
leukocyte function
modulating leukocyte
soluble
Prior art date
Application number
IL107432A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL107432A0 publication Critical patent/IL107432A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
IL107432A 1992-10-30 1993-10-28 Soluble lymphocyte receptor protein and a method for modulating leukocyte function IL107432A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96970092A 1992-10-30 1992-10-30

Publications (1)

Publication Number Publication Date
IL107432A0 true IL107432A0 (en) 1994-01-25

Family

ID=25515876

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107432A IL107432A0 (en) 1992-10-30 1993-10-28 Soluble lymphocyte receptor protein and a method for modulating leukocyte function

Country Status (8)

Country Link
EP (1) EP0595659A3 (xx)
JP (1) JPH072899A (xx)
AU (1) AU5034493A (xx)
CA (1) CA2109398A1 (xx)
FI (1) FI934751A (xx)
IL (1) IL107432A0 (xx)
MX (1) MX9306682A (xx)
NO (1) NO933860L (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7405270B2 (en) 1991-10-25 2008-07-29 Immunex Corporation CD40-Ligand lacking native-pattern glycosylation
US5962406A (en) * 1991-10-25 1999-10-05 Immunex Corporation Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
US5981724A (en) 1991-10-25 1999-11-09 Immunex Corporation DNA encoding CD40 ligand, a cytokine that binds CD40
US5246113A (en) * 1992-02-11 1993-09-21 Riverwood International Corporation Carrier for stacked articles
US5683693A (en) 1994-04-25 1997-11-04 Trustees Of Dartmouth College Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
IL129138A0 (en) 1996-10-11 2000-02-17 Bristol Myers Squibb Co Methods and compositions for immunomodulation
AU1288099A (en) * 1997-10-30 1999-05-24 Cornell Research Foundation Inc. A method of inhibiting an immune response to a recombinant vector
AU2007341631B9 (en) 2006-12-28 2012-10-04 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo
RU2652348C2 (ru) 2012-07-18 2018-04-25 Аподжиникс Аг Ингибиторы сигнального пути cd95 для лечения мдс
JP2014184804A (ja) 2013-03-22 2014-10-02 Toyota Motor Corp 車両用動力伝達装置の制御装置
EP3076179A1 (en) 2015-03-30 2016-10-05 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Diagnosis and treatment of low grade gliomas
US20180244792A1 (en) * 2015-09-10 2018-08-30 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Anti-fibrotic effect of cd70
BR112021019328A2 (pt) 2019-03-29 2021-11-30 Myst Therapeutics Llc Métodos ex vivo para produzir um produto terapêutico de célula t e composições e métodos relacionados
CA3162703A1 (en) 2019-11-27 2021-06-03 Myst Therapeutics, Llc Method of producing tumor-reactive t cell composition using modulatory agents
MX2022010517A (es) 2020-02-27 2022-11-14 Myst Therapeutics Llc Metodos para la expansion y enriquecimiento ex vivo de celulas t reactivas a tumor y composiciones relacionadas de las mismas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3149289A (en) * 1988-03-18 1989-09-21 Rockefeller University, The Method and agent for inhibiting the binding of human polymorphonuclear leukocytes to endothelium and compositions therefor
US5057604A (en) * 1988-08-03 1991-10-15 Washington University Novel monoclonal antibodies
US5204445A (en) * 1988-10-03 1993-04-20 The Scripps Research Institute Peptides and antibodies that inhibit integrin-ligand binding
US5169930A (en) * 1990-01-05 1992-12-08 La Jolla Cancer Research Foundation Fibronectin receptor
WO1991019511A1 (en) * 1990-06-18 1991-12-26 The General Hospital Corporation CONTROLLING CELLULAR IMMUNE/INFLAMMATORY RESPONSES WITH β2 INTEGRINS

Also Published As

Publication number Publication date
CA2109398A1 (en) 1994-05-01
NO933860D0 (no) 1993-10-27
NO933860L (no) 1994-05-02
EP0595659A2 (en) 1994-05-04
FI934751A0 (fi) 1993-10-27
EP0595659A3 (en) 1995-01-11
FI934751A (fi) 1994-05-01
AU5034493A (en) 1994-05-12
MX9306682A (es) 1994-04-29
JPH072899A (ja) 1995-01-06

Similar Documents

Publication Publication Date Title
EP0588502A3 (en) System and methods for file management
GB8806858D0 (en) System & method for integral transforms
AU5606194A (en) System and method for profiling a patella
EP0823159A4 (en) METHOD AND DEVICES FOR SECURING THE TRANSMISSION OF NEWS WITHIN A AREA
IL107432A0 (en) Soluble lymphocyte receptor protein and a method for modulating leukocyte function
GB2226001B (en) Refuse conveyer system
AU3251089A (en) Method for depositing particles and a binder system on a base fabric
GB2216362B (en) Apparatus and method for area designation on a document
AU7956091A (en) A portable cover system and method for vehicular use
EP0362966A3 (en) Catalysts and methods for denitrization
AU3878889A (en) Irreversible peptide ligands for bombesin receptors
GB8909350D0 (en) File system
ZA897627B (en) Method and apparatus for effecting a biogeaction
AU3031289A (en) File location system
GB8905264D0 (en) Priority valve and method for using same
GB2220041B (en) Hose connecting system and method for providing a hose connecting system
GB2265591B (en) Track component for a track system
AU2748688A (en) Method and apparatus for a tele-communication system
IL102948A0 (en) Gelcoated-fiberglass and a method for its preparation
AU4460993A (en) Method and apparatus for forming a branch connection
EP0586821A3 (en) Method and apparatus for cutting a belt-shaped member
GB2223289B (en) A joint system
EP0483765A3 (en) Method for activating lymphocyte
GB2264666B (en) Apparatus and method for cutting a mountboard
GB9202999D0 (en) A turkey processing system